Cedric Hermans/institutroialbertdeux.be
Apr 3, 2026, 13:56
Cedric Hermans: A New Viewpoint on Rebalancing Coagulation in Haemophilia
Cedric Hermans, Head of Haemophilia Centre at the Saint-Luc University Hospital, Brussels, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Very happy to share this other viewpoint paper I co-authored with Quentin Van Thillo, Glenn Pierce and Maria Elisa Mancuso entitled ‘Balancing the benefits and risks of rebalancing coagulation in haemophilia’ and released this week in the Lancet Haematology”
Tilte: Balancing the benefits and risks of rebalancing coagulation in haemophilia
Authors: Cedric Hermans, Quentin Van Thillo, Glenn F Pierce, Maria Elisa Mancuso
Read the Full Article on The Lancet Haematology
Other posts featuring Cedric Hermans on Hemostasis Today.
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’